| Schedule of Condensed Balance Sheets |
Condensed
Balance Sheets
| | |
As
of December 31, | |
| | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
| ASSETS | |
| | |
| | |
| |
| Current
assets: | |
| | |
| | |
| |
| Cash | |
| 153 | | |
| 15,627 | | |
| 2,235 | |
| Total
current assets | |
| 153 | | |
| 15,627 | | |
| 2,235 | |
| | |
| | | |
| | | |
| | |
| Non-current
assets: | |
| | | |
| | | |
| | |
| Investment
in subsidiaries | |
| 283,952 | | |
| 216,526 | | |
| 30,957 | |
| Other
receivables | |
| - | | |
| 23,392 | | |
| 3,345 | |
| Deferred
IPO expenses | |
| 2,571 | | |
| - | | |
| - | |
| Total
non-current assets | |
| 286,523 | | |
| 239,918 | | |
| 34,302 | |
| Total
assets | |
| 286,676 | | |
| 255,545 | | |
| 36,537 | |
| | |
| | | |
| | | |
| | |
| LIABILITIES
AND SHAREHOLDERS’ EQUITY | |
| | | |
| | | |
| | |
| Accounts
payable | |
| - | | |
| 130 | | |
| 19 | |
| Accrued
expenses and other liabilities | |
| 2,571 | | |
| - | | |
| - | |
| Amount
due to related parties | |
| 146 | | |
| - | | |
| - | |
| Due
to subsidiaries | |
| - | | |
| 5,567 | | |
| 796 | |
| Total
liabilities | |
| 2,717 | | |
| 5,697 | | |
| 815 | |
| | |
| | | |
| | | |
| | |
| Commitments
and contingencies | |
| | | |
| | | |
| | |
| Shareholders’
equity: | |
| | | |
| | | |
| | |
| Class A ordinary shares (US$0.000025 par value; 1,900,000,000 shares authorized;
5,666,376 and 7,391,376 shares issued and outstanding as of December 31, 2024 and 2025, respectively)* | |
| 1 | | |
| 1 | | |
| - | |
| Class B ordinary shares (US$0.000025 par value; 100,000,000 shares
authorized; 40,000,000 and 40,000,000shares issued and outstanding as of December 31, 2024 and 2025, respectively)* | |
| 7 | | |
| 7 | | |
| 1 | |
| Additional
paid-in capital | |
| 203,150 | | |
| 240,752 | | |
| 34,427 | |
| Statutory
reserve | |
| 32,647 | | |
| 32,647 | | |
| 4,668 | |
| Retained
earnings (deficit) | |
| 48,151 | | |
| (21,633 | ) | |
| (3,099 | ) |
| Accumulated
other comprehensive income | |
| 3 | | |
| (1,926 | ) | |
| (275 | ) |
| Total
shareholders’ equity | |
| 283,959 | | |
| 249,848 | | |
| 35,722 | |
| Total
liabilities and shareholders’ equity | |
| 286,676 | | |
| 255,545 | | |
| 36,537 | |
| * | As
of December 31, 2025, share reclassification was retroactively restated with effective date of March 24, 2026. |
|
| Schedule of Condensed Statements of Comprehensive Income (loss) |
Condensed
Statements of Comprehensive Income (loss)
| | |
For
the years ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Operating costs and expenses: | |
| | |
| | |
| | |
| |
| Selling,
general and administrative | |
| - | | |
| (2 | ) | |
| (2,358 | ) | |
| (339 | ) |
| Operating
income | |
| | | |
| | | |
| | | |
| | |
| Share
of income of subsidiaries | |
| 31,457 | | |
| 11,313 | | |
| (67,426 | ) | |
| (9,643 | ) |
| Net
income | |
| 31,457 | | |
| 11,311 | | |
| (69,784 | ) | |
| (9,982 | ) |
| Other
comprehensive income (loss) | |
| | | |
| | | |
| | | |
| | |
| Foreign
currency translation adjustment | |
| — | | |
| 3 | | |
| (1,929 | ) | |
| (275 | ) |
| Total
comprehensive income (loss) | |
| 31,457 | | |
| 11,314 | | |
| (71,713 | ) | |
| (10,257 | ) |
|
| Schedule of Condensed Statements of Cash Flows |
Condensed
Statements of Cash Flows
| | |
For the years ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Cash flows from operating activities: | |
| | |
| | |
| | |
| |
| Net income (loss) | |
| 31,457 | | |
| 11,311 | | |
| (69,784 | ) | |
| (9,982 | ) |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | |
| | | |
| | | |
| | | |
| | |
| Amount due to subsidiary | |
| - | | |
| - | | |
| 90 | | |
| 13 | |
| Other receivables | |
| - | | |
| - | | |
| (23,393 | ) | |
| (3,345 | ) |
| Accounts payable | |
| - | | |
| - | | |
| 130 | | |
| 19 | |
| Accrued expenses and other liabilities | |
| - | | |
| 2,571 | | |
| - | | |
| - | |
| Amount due to related parties | |
| - | | |
| 146 | | |
| (146 | ) | |
| (20 | ) |
| Equity in of subsidiaries | |
| (31,457 | ) | |
| (11,313 | ) | |
| 67,426 | | |
| 9,643 | |
| Net cash provided by (used in) operating activities | |
| - | | |
| 2,715 | | |
| (25,677 | ) | |
| (3,672 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Cash flows from financing activities: | |
| | | |
| | | |
| | | |
| | |
| Proceeds from shareholder | |
| 9 | | |
| - | | |
| 43,080 | | |
| 6,160 | |
| Deferred IPO expenses | |
| - | | |
| (2,571 | ) | |
| - | | |
| - | |
| Net cash used in (provided by) financing activities | |
| 9 | | |
| (2,571 | ) | |
| 43,080 | | |
| 6,160 | |
| | |
| | | |
| | | |
| | | |
| | |
| Effect of exchange rate changes on cash | |
| - | | |
| - | | |
| (1,929 | ) | |
| (275 | ) |
| Net increase in cash | |
| 9 | | |
| 144 | | |
| 15,474 | | |
| 2,213 | |
| Cash, beginning of year | |
| - | | |
| 9 | | |
| 153 | | |
| 22 | |
| Cash, end of year | |
| 9 | | |
| 153 | | |
| 15,627 | | |
| 2,235 | |
|